Why the study?
Does sublingual captopril reduce adverse effects while maintaining antihypertensive efficacy compared to sublingual nifedipine in patients with hypertensive crisis?
Does sublingual captopril reduce adverse effects while maintaining antihypertensive efficacy compared to sublingual nifedipine in patients with hypertensive crisis?
Sublingual captopril is as effective as sublingual nifedipine for hypertensive crisis but has a significantly better safety profile with fewer adverse effects.
No takes yet. Share an insight, caveat, or question.
May prefer sublingual captopril to nifedipine in hypertensive crisis; confirms comparable efficacy with markedly better tolerability.
Gemici et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: